What is the official website of Wockhardt Ltd. ?

The official website of Wockhardt Ltd. is http://www.wockhardt.com.

What is Wockhardt Ltd.'s cybersecurity risk score?

Wockhardt Ltd. has an AI-generated cybersecurity risk score of 840 out of 1000, indicating a Good security posture according to Rankiteo's assessment.

How many security incidents has Wockhardt Ltd. experienced?

According to Rankiteo, Wockhardt Ltd. currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.

Has Wockhardt Ltd. been affected by any supply chain cyber incidents ?

According to Rankiteo, Wockhardt Ltd. has not been affected by any supply chain cyber incidents, and no incident IDs are currently listed for the organization.

Does Wockhardt Ltd. have SOC 2 Type 1 certification ?

According to Rankiteo, Wockhardt Ltd. is not certified under SOC 2 Type 1.

Does Wockhardt Ltd. have SOC 2 Type 2 certification ?

According to Rankiteo, Wockhardt Ltd. does not hold a SOC 2 Type 2 certification.

Does Wockhardt Ltd. comply with GDPR ?

According to Rankiteo, Wockhardt Ltd. is not listed as GDPR compliant.

Does Wockhardt Ltd. have PCI DSS certification ?

According to Rankiteo, Wockhardt Ltd. does not currently maintain PCI DSS compliance.

Does Wockhardt Ltd. comply with HIPAA ?

According to Rankiteo, Wockhardt Ltd. is not compliant with HIPAA regulations.

Does Wockhardt Ltd. have ISO 27001 certification ?

According to Rankiteo,Wockhardt Ltd. is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.

Which industry does Wockhardt Ltd. operate in ?

Wockhardt Ltd. operates primarily in the Pharmaceutical Manufacturing industry.

How many employees does Wockhardt Ltd. have ?

Wockhardt Ltd. employs approximately 7,259 people worldwide.

Does Wockhardt Ltd. own any subsidiaries ?

Wockhardt Ltd. presently has no subsidiaries across any sectors.

How many LinkedIn followers does Wockhardt Ltd. have ?

Wockhardt Ltd.'s official LinkedIn profile has approximately followers.

What is the NAICS classification code for Wockhardt Ltd. ?

Wockhardt Ltd. is classified under the NAICS code 3254, which corresponds to Pharmaceutical and Medicine Manufacturing.

Does Wockhardt Ltd. have a Crunchbase profile ?

Yes, Wockhardt Ltd. has an official profile on Crunchbase, which can be accessed here: https://www.crunchbase.com/organization/wockhardt.

Does Wockhardt Ltd. have a LinkedIn profile ?

Yes, Wockhardt Ltd. maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/wockhardt.

How many cybersecurity incidents has Wockhardt Ltd. experienced ?

As of September 16, 2026, Rankiteo reports that Wockhardt Ltd. has experienced 1 cybersecurity incidents.

How many peer or competitor companies does Wockhardt Ltd. have ?

Wockhardt Ltd. has an estimated 5,763 peer or competitor companies worldwide.

What types of cybersecurity incidents has Wockhardt Ltd. faced ?

Incident Types: The types of cybersecurity incidents that have occurred include Breach.

Badge your company to reduce your risk score and your cyber insurance costs!

Link verified badges to your company page to build trust with insurers and customers.

Apply now and get your badge!

Internal validation & live display

Insurers and partners see a safer profile

Faster underwriting decisions

Trusted by insurers. Chosen by leaders.

Proud contributor to the Society of Actuaries.

Wockhardt Ltd.

Boost Score +25 with badge (5 left)

840

/1000

Good

865

/1000

Very Good

Wockhardt Ltd. Vendor Cyber Rating & Cyber Score

wockhardt.com

cb in

Add Your Compliance Badge

Wockhardt is a global pharmaceutical and biotechnology organization, providing affordable, high-quality medicines for a healthier world. It is India’s leading research-based global healthcare enterprise with relevance in the fields of Pharmaceuticals, Biotechnology and a chain of advanced Super Specialty Hospitals. Wockhardt is a true Indian Multi-National Company with a multi-ethnic workforce of 3000 Wockhardt Associates from 21 different nationalities globally. It has 3 research centers and 12 manufacturing plants, with businesses ranging from the manufacture and marketing of Pharmaceutical and Bio-pharmaceutical formulations, Active Pharmaceutical Ingredients (APIs) and Vaccines. Headquartered in Mumbai, India, Wockhardt has

Wockhardt Ltd.

Wockhardt Ltd. CyberSecurity News & History

Past Incidents

Attack Types

Entity

Type

Severity

Impact

Seen

Blog Details

Supply Chain Source

Incident Details

View

Wockhardt Ltd.

Breach

12/2025

WOC1764906951

Loading…

A.I.

Wockhardt Ltd. Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Actual

Prediction

Incident Predictions locked

Access Monitoring Plan

A.I Risk Score Likelihood 3 - 6 - 9 months

Actual

Prediction A

Prediction B

Prediction C

Prediction D

A.I. Risk Score Predictions locked

Access Monitoring Plan

Loading…

Underwriter Stats for Wockhardt Ltd.

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Wockhardt Ltd. in 2026.

Incidents vs All-Companies Average (This Year)

No incidents recorded for Wockhardt Ltd. in 2026.

Incident Types Wockhardt Ltd. vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Wockhardt Ltd. in 2026.

Incident History - Wockhardt Ltd. (X = Date, Y = Severity)

Loading…

SUBSIDIARY

Wockhardt Ltd. Subsidiaries

Wockhardt Ltd.

Pharmaceutical Manufacturing

Website: http://www.wockhardt.com

Company Size: 7,259

Wockhardt USAPharmaceutical Manufacturing

Loading…

Wockhardt Ltd. Similar Companies

Novo Nordisk

cb novonordisk.com

We’re not your typical healthcare company. In a modern world of quick fixes, we focus on solutions to defeat serious chronic disease and create long-term health. We seek out new ideas and put people first as we push the boundaries of science, make healthcare more accessible, and work to treat, prevent, and even cure diseases that affect millions of lives. Founded in Denmark in 1923, today we employ more than 68,800 people in 80 offices around the world – all united by our bold purpose to drive change to defeat serious chronic diseases. Want to learn more? Visit www.novonordisk.com. This page isn’t intended for discussions about products. As such, postings or comments that contain product discussions may be removed. This page is for discussions about Novo Nordisk and its subsidiaries and the initiatives and projects we are involved in. While we welcome everyone to make comments, we reserve the right to block and remove those that are off-topic, abusive or intended to spam. Any questions specific to products should be made to your healthcare professional. If you wish to file an adverse drug reaction please contact Novo Nordisk’s office in the country you live in: https://www.novonordisk.com/contact-us/find-local-information.html For other customer complaints, please contact us here: https://www.novonordisk.com/contact-us.html Please keep in mind that Novo Nordisk A/S and its subsidiaries work within a highly regulated industry. Therefore, comments that pertain to legal matters or regulatory issues may be removed. Comments contained on this site come from members of the public, and do not necessarily reflect the views of Novo Nordisk A/S. Novo Nordisk A/S does not endorse or approve any content added by other LinkedIn users. Learn more about our privacy disclaimer and community guidelines here: https://www.novonordisk.com/data-privacy-and-user-rights/social-media-privacy-disclaimer.html

UCB

cb ucb.com

At UCB, we believe everyone deserves to live the best life they can - as free as possible from the challenges and uncertainty of disease. Our purpose is to support people living with severe central nervous system and immunological conditions by delivering meaningful solutions that go beyond medicine. We are driven by the experiences of patients and caregivers, and inspired to pursue innovations that create real value - not just in clinical outcomes, but in everyday moments, dreams pursued, and simple pleasures enjoyed. Our ambition is to unlock transformative science and technologies that respond to unmet needs and elevate lives. From our headquarters in Belgium to nearly 40 countries around the world, we nurture a culture of respect and care. By listening deeply and collaborating across borders and disciplines, we enable cutting-edge research shaped by patients’ needs. Through strong connections with healthcare professionals, partners, and communities, we strive to make a lasting impact - today and into the future. We're inspired by patients, driven by science.

SUN PHARMA

sunpharma.com

Sun Pharma is the world's fourth-largest speciality generic pharmaceutical company and No. 1 in India. We provide high-quality, affordable medicines trusted by customers and patients in over 100 countries. Sun Pharma's global presence is supported by more than 40 manufacturing facilities spread across 5 continents, R&D centres across the globe, and a multicultural workforce comprising over 50 nationalities. Sun Pharma fosters excellence through innovation supported by strong R&D capabilities comprising around 3,000 scientists and R&D investments of over 6-8% of annual revenues. At Sun, our people are our greatest asset. Ours has never been a story of individual brilliance but of cultivating a culture of realising collective potential. In our journey, everyone is enabled to take charge in an environment that offers limitless growth opportunities. We are with you every step of the way, so you can shine for years to come. With the launch of our Employee Value Proposition (EVP), we define our promise to ‘Create Your Own Sunshine'—driven by the three pillars of Better Every Day, Take Charge, and Thrive Together. These pillars drive progress at Sun so that people can achieve what they would have thought impossible. Learn more about our EVP here: https://sunpharma.com/careers/

Takeda

cb takeda.com

We strive to transform lives. While the science we advance is constantly evolving, our core purpose is enduring. For more than two centuries, our values have guided us to do what’s right for patients and for society. We know that changing lives requires us to do things differently. We start by listening to and addressing what really matters to patients, the people who love them, and those in the healthcare system who provide care. And that’s what inspires us all to be bold, push boundaries and set new standards that open up greater opportunities. Read our community guidelines: https://takeda.info/communityguidelines

Eli Lilly and Company

lilly.com

We're a medicine company turning science into healing to make life better for people around the world. It all started nearly 150 years ago with a clear vision from founder Colonel Eli Lilly: "Take what you find here and make it better and better." Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing science to solve some of the world's most significant health challenges. General Information and Guidelines: When you engage with us on LinkedIn, you're agreeing to these Community Guidelines: https://e.lilly/guidelines. If you have questions about a Lilly medicine, contact The Lilly Answers Center at 1-800-Lilly-Rx (1-800-545-5979) Monday through Friday, excluding company holidays.

EMS

cb ems.com.br

Fundada há mais de 60 anos e com capital 100% nacional, a EMS é a líder do mercado farmacêutico brasileiro há 19 anos consecutivos, pertencente ao Grupo NC, um dos maiores conglomerados brasileiros. A empresa ocupa também a liderança no segmento de genéricos desde 2013 (IQVIA 2019) e está entre os maiores laboratórios em preferência prescritiva no Brasil. Tem forte presença em PDVs de todo o país e atuação nas áreas de Prescrição Médica, Genéricos, Marcas, OTC e Hospitalar, fabricando medicamentos para praticamente todas as especialidades da Medicina. Possui fábricas em Hortolândia (SP), Manaus (AM), Brasília (DF) e Jaguariúna (SP). A EMS apoia ações de responsabilidade social dentro e fora do Brasil. Em 2017, por exemplo, o laboratório fechou parceria com a Organização Mundial da Saúde (OMS) para doar 100% do medicamento para erradicar, nos próximos anos, em todo o planeta, a bouba, doença negligenciada. A EMS é a única farmacêutica no mundo a ter abraçado essa causa. O Centro de Pesquisa & Desenvolvimento da EMS no Brasil é o mais moderno da América Latina. Na Itália, a EMS tem o laboratório de pesquisas MonteResearch. O foco de atuação do laboratório é a inovação nas seguintes frentes: inovação incremental; genéricos de alta complexidade; medicamentos biotecnológicos, por meio da empresa Bionovis; e inovação disruptiva, por meio da Brace Pharma, empresa da EMS instalada em 2013 nos Estados Unidos. Ainda, nos EUA, por meio de sua controlada Vero Biotech, localizada em Atlanta, Geórgia, a EMS, recentemente, obteve a aprovação de seu primeiro produto revolucionário submetido à FDA (Food and Drug Administration), posicionando o laboratório como uma empresa de inovação no mercado global. Com aportes frequentes em infraestrutura fabril e em pesquisa de ponta para desenvolver produtos inovadores, eficazes e seguros, a EMS, que já exporta para mais de 40 países, está preparada para continuar cuidando das pessoas que querem viver cada vez mais e melhor.

Cipla

cipla.com

Cipla is a leading global pharmaceutical company trusted by healthcare professionals and patients across the world since 1935. A compassionate approach to healthcare that goes beyond the pursuit of profit and growth has been the force impelling Cipla’s history over the years. Our credo and our purpose of ‘Caring for Life' continues to guide our actions towards our people and the planet for creating a sustainable future. Cipla today has presence in 80+ countries, providing over 1,500 products across various therapeutic categories in 50+ dosage forms. Keeping with our legacy of care, we constantly strive to ensure access to high-quality medicines that make a difference in the lives of patients. Our paradigm-changing offer of a triple anti-retroviral (ARV) therapy in HIV/AIDS at less than a dollar a day in Africa in 2001 was pivotal in bringing inclusiveness, accessibility and affordability to the centre of the HIV movement. An unmatched presence across the care continuum (awareness, prevention, diagnosis, treatment and adherence) and the widest range of drug-device combinations has established Cipla’s respiratory leadership in India and other key emerging markets. Armed with this legacy and a deep understanding of the lungs, we have articulated our aspiration to become a global lung leader and help millions breathe free.

Bristol Myers Squibb

cb bms.com

At Bristol Myers Squibb, we work every day to transform patients’ lives through science. That work inspires some of the most interesting, meaningful, and life-changing careers you’ll experience. Join us and pursue innovative ideas alongside some of the brightest minds in biopharma, collaborating with a team rich in diversity of experiences, and perspectives. We have built a sustainable pipeline of potential therapies and are leveraging translational medicine and data analytics to understand how we can deliver the right medicine to the right patient, at the right time, to achieve the best outcome. Whether in a scientific, business or supporting function, a career at BMS means you’ll be inspired every day to grow and thrive through opportunities that are uncommon in scale and scope. Here, you’ll be on the cutting edge of powerful innovation in oncology, hematology, immunology, cardiovascular disease, and fibrosis, with colleagues united in the mission to help patients. Through the Bristol Myers Squibb Foundation, we also promote health equity and seek to improve health outcomes of populations disproportionately affected by serious diseases and conditions. Our mission is to give new hope to help patients prevail over serious disease – it drives everything we do. Review our Social Media Community Guidelines at: https://www.bms.com/social-media-community-guidelines.html

Merck Group

merckgroup.com

This channel is not intended for U.S. and Canadian visitors. Merck operates in the U.S. and Canada as EMD Serono in Healthcare, MilliporeSigma in Life Science and EMD Electronics in Electronics. An unaffiliated and unrelated company, Merck & Co., Inc., Kenilworth, NJ, US holds the rights in the trademark MERCK in the U.S. and Canada. _______________________________ We are Merck, a leading global science and technology company headquartered in Germany. We are curious explorers, courageous pioneers, and ingenious inventors. Our colleagues across the globe love innovating with science and technology to enrich people’s lives with our solutions in Life Science, Healthcare, and Electronics. Together, we dream big and are passionate about caring for our rich mix of people, customers, patients, and the planet. We believe in the positive power of science and technology. It has determined our actions since 1668 and inspires us to continue researching for a future worth living. As a family-owned company with over 350 years of experience, we stand for sustainability, responsibility, and innovative strength. We take pride in being a diverse and inclusive company that values and fosters the talents and abilities of our employees. That's why we are always looking for curious minds that see themselves imagining the unimaginable with us. Work your Magic and join Merck. Legal Disclaimer: www.merckgroup.com/en/legal-disclaimer.html Data Privacy Declaration: www.merckgroup.com/en/privacy-statement

Loading…

NEWS

Wockhardt Ltd. CyberSecurity News

Latest updates, reports, and threat intel affecting the global network.

September 12, 2025 07:00 AM

Wockhardt-Shukra Pharma deal: Pharma majors sign pan-India distribution pact - Details

Distribution Deal: According to a PTI report, Shukra Pharma has entered into a pan-India distribution deal with global pharmaceutical and...

Read Article

September 10, 2025 07:00 AM

'Some data' affected by cybersecurity incident, says Jaguar Land Rover

Jaguar Land Rover confirmed that "some data" was impacted in a recent cyberattack that disrupted production and sales.

Read Article

Loading…

CVE

Latest

Global CVEs (Not Company-Specific)

CVE-2026-85893

SUMMARY

Use after free in Microsoft Edge (Chromium-based) allows an unauthorized attacker to elevate privileges over a network.

Published

Date2026-09-15

Updated

Date2026-09-15

RISK INFORMATION (Score: 8.8)

cvss3

Base Score: 8.8

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:H/I:H/A:H

Impact Score

5.9

Exploitability

2.8

REFERENCES

https://msrc.microsoft.com/update-guide/vulnerability/CVE-2026-85893

CVE-2026-69486

SUMMARY

Heap-based buffer overflow in Microsoft Edge (Chromium-based) allows an unauthorized attacker to execute code over a network.

Published

Date2026-09-15

Updated

Date2026-09-15

RISK INFORMATION (Score: 8.8)

cvss3

Base Score: 8.8

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:H/I:H/A:H

Impact Score

5.9

Exploitability

2.8

REFERENCES

https://msrc.microsoft.com/update-guide/vulnerability/CVE-2026-69486

CVE-2025-11395

SUMMARY

A flaw was found in Podman. If an attacker can pass a crafted tar archive to the `podman load` command, they can create files on the host machine with the privileges of the user running Podman.

Published

Date2026-09-15

Updated

Date2026-09-15

RISK INFORMATION (Score: 5.5)

cvss3

Base Score: 5.5

Complexity: LOW

CVSS:3.1/AV:A/AC:L/PR:L/UI:N/S:U/C:L/I:L/A:L

Impact Score

3.4

Exploitability

2.1

REFERENCES

CVE-2026-92259

SUMMARY

Integer overflow or wraparound vulnerability in Samsung Opensource Escargot allows attackers with write access to the bytecode-cache directory to cause a heap-based buffer overflow and denial of service via a crafted cache file. This issue affects Escargot: ac94df78493ee6fede286620d94f724e46b4d238.

Published

Date2026-09-15

Updated

Date2026-09-15

RISK INFORMATION (Score: 5.5)

cvss3

Base Score: 5.5

Complexity: LOW

CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:N/I:N/A:H

Impact Score

3.6

Exploitability

1.8

REFERENCES

https://github.com/Samsung/escargot/pull/1650

CVE-2026-92257

SUMMARY

Netcore NR255-V version 1.5.130703 contains a stored cross-site scripting vulnerability in L7 content management pages that use eval() sinks, affecting the call board text and policy group handling components. Attackers can inject persistent script payloads through these pages to have malicious code executed in the context of other users viewing the affected content.

Published

Date2026-09-15

Updated

Date2026-09-15

RISK INFORMATION (Score: 5.4)

cvss3

Base Score: 5.4

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:C/C:L/I:L/A:N

cvss4

Base Score: 5.1

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:P/VC:L/VI:L/VA:N/SC:L/SI:L/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

2.7

Exploitability

2.3

REFERENCES

Loading…

API

Access Data Using Our API

Get company history

curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?
linkedin_id=axa' -H 'apikey: YOUR_API_KEY_HERE'

Try It API Documentation Rapid

MEASURE

What Do We Measure ?

Incident

Finding

Grade

Digital Assets

Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.

These are some of the factors we use to calculate the overall score:

Network SecurityIdentify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.

SBOM (Software Bill of Materials)Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.

CMDB (Configuration Management Database)Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.

Threat IntelligenceLeverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.

Rankiteo

By Rankiteo

★ ★ ★ ★ ★

View on G2.com

Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.

View latest plans →View all security reports →

MILESTONEG

Users
Love Us

Loading…

Badge your company to reduce your risk score and your cyber insurance costs!

Trusted by insurers. Chosen by leaders.

Wockhardt Ltd. Vendor Cyber Rating & Cyber Score

Wockhardt Ltd. A.I CyberSecurity Scoring

Wockhardt Ltd. CyberSecurity News & History

Wockhardt Ltd. Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Incident Predictions locked

A.I Risk Score Likelihood 3 - 6 - 9 months

A.I. Risk Score Predictions locked

Underwriter Stats for Wockhardt Ltd.

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

Incidents vs All-Companies Average (This Year)

Incident Types Wockhardt Ltd. vs Pharmaceutical Manufacturing Industry Avg (This Year)

Incident History - Wockhardt Ltd. (X = Date, Y = Severity)

Wockhardt Ltd. Subsidiaries

Wockhardt Ltd.

Wockhardt Ltd. Similar Companies

Novo Nordisk

UCB

SUN PHARMA

Takeda

Eli Lilly and Company

EMS

Cipla

Bristol Myers Squibb

Merck Group

Wockhardt Ltd. CyberSecurity News

Wockhardt-Shukra Pharma deal: Pharma majors sign pan-India distribution pact - Details

'Some data' affected by cybersecurity incident, says Jaguar Land Rover

Global CVEs (Not Company-Specific)

Access Data Using Our API

What Do We Measure ?

These are some of the factors we use to calculate the overall score:

Rankiteo

Wockhardt Ltd. CyberSecurity News & History

Wockhardt Ltd. Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Incident Predictions locked

A.I Risk Score Likelihood 3 - 6 - 9 months

A.I. Risk Score Predictions locked

Underwriter Stats for Wockhardt Ltd.

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

Incidents vs All-Companies Average (This Year)

Incident Types Wockhardt Ltd. vs Pharmaceutical Manufacturing Industry Avg (This Year)

Incident History - Wockhardt Ltd. (X = Date, Y = Severity)

Wockhardt Ltd. Subsidiaries

Wockhardt Ltd.

Wockhardt Ltd. Similar Companies

Novo Nordisk

UCB

SUN PHARMA

Takeda

Eli Lilly and Company

EMS

Cipla

Bristol Myers Squibb

Merck Group

Wockhardt Ltd. CyberSecurity News

Wockhardt-Shukra Pharma deal: Pharma majors sign pan-India distribution pact - Details

'Some data' affected by cybersecurity incident, says Jaguar Land Rover

Global CVEs (Not Company-Specific)

Access Data Using Our API

What Do We Measure ?

These are some of the factors we use to calculate the overall score:

Rankiteo